首页> 外文会议>International Symposium on Therapeutic Ultrasound (2002- ) >Endocavity Ultrasound Hyperthermia for Locally Advanced Cervical Cancer: Patient-specific Modeling, Experimental Verification, and Combination with HDR Brachytherapy
【24h】

Endocavity Ultrasound Hyperthermia for Locally Advanced Cervical Cancer: Patient-specific Modeling, Experimental Verification, and Combination with HDR Brachytherapy

机译:内胶质超声热疗用于局部晚期宫颈癌:患者特异性建模,实验验证和HDR近距离放射治疗的组合

获取原文

摘要

The feasibility of targeted hyperthermia delivery by an intrauterine ultrasound applicator to patient-specific treatment volumes in conjunction with HDR brachytherapy was investigated using theory and experiment. 30 HDR brachytherapy treatment plans were inspected to define hyperthermia treatment volumes (HTVs) based on tumor and radiation target volumes. Several typical cases were imported into a patient-specific treatment planning platform that optimized acoustic output power from an endocavity multisectored tubular array to conform temperature and thermal dose to HTVs. Perfusion was within a clinical range of 0.5-3 kg m~(-3) s~(-1). Applicators were constructed with 1-3 elements at 6.5 - 8 MHz with 90deg-360deg sectoring and 25-35 mm heating length housed in a water-cooled PET catheter. Acoustic output was compared to heating in ex vivo tissue assessed with implanted thermometry. Radiation attenuation through the device was measured in an ionization chamber. The HTV extends 2-4 cm in diameter and 2-4 cm in length. The bladder and rectum can be within 10-12 mm. HTV targets can be covered with temperature clouds >41deg and thermal dose t~(43) >5 min with 45degC maximum temperature and rectal temperature <41.5degC. Sectored applicators preferentially direct energy laterally into the parametrium to limit heating of rectum and bladder. Interstitial brachytherapy catheters within the HTV could be used for thermal feedback during HT treatment Temperature distributions in phantom show preferential heating within sectors and align well with acoustic output. Heating control along the device length and in angle is evident. A 4-6% reduction in radiation transmission through the transducers was observed, which could likely be compensated for in planning. Patient-specific modeling and experimental heating demonstrated 3-D conformal heating capabilities of endocavity ultrasound applicators.
机译:使用理论和实验研究了宫内超声施加器与患者特异性处理体积的宫内超声施加患者特异性治疗体积的可行性。检查30 HDR近距离放射治疗计划,以根据肿瘤和辐射靶体积定义高温治疗体积(HTV)。将几种典型的病例进口到患者特定的治疗计划平台中,该平台优化了来自内胶质多传输管状阵列的声学输出功率,以适应温度和热量给HTV。灌注在0.5-3kg m〜(-3)s〜(-1)的临床范围内。涂布器由6.5 - 8 MHz的1-3元元素,90deg-360deg扇区和25-35毫米加热长度容纳在水冷宠物导管中。将声学输出与用植入的温度评估的离体组织中加热进行比较。通过装置的辐射衰减在电离室中测量。 HTV直径延伸2-4厘米,长度为2-4厘米。膀胱和直肠可以在10-12毫米内。 HTV靶标可以覆盖温度云> 41deg和热剂量T〜(43)> 5分钟,45℃最大温度和直肠温度<41.5degc。部门施用者优先直接能量横向地进入参数,以限制直肠和膀胱的加热。 HTV内的间隙近距离放射治疗导管可用于在HT处理温度分布期间用于热反馈,在扇区内显示优先加热并用声输出良好地对齐。沿着装置长度和角度的加热控制很明显。观察到通过换能器的辐射传输减少4-6%,这可能会在规划中得到补偿。患者特异性建模和实验加热证明了内筒瘤超声施加器的3-D保形加热能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号